DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Parkinson's disease	R-HSA-1643685	0	sulfamethoxypyridazine	5330	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	sulfamethoxypyridazine	5330	drug-path
Apoptosis	R-HSA-109581	map04210	sulfamethoxypyridazine	5330	drug-path
B cell receptor signaling pathway	R-HSA-983705	map04662	cloperastine	23306	drug-path
Huntington's disease	R-HSA-1643685	0	cloperastine	23306	drug-path
Olfactory transduction	R-HSA-9751605	map04740	cloperastine	23306	drug-path
Cell adhesion molecules (CAMs)	R-HSA-1031690	0	cloperastine	23306	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	cloperastine	23306	drug-path
Bladder cancer	R-HSA-9700206	map05219	cloperastine	23306	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	cloperastine	23306	drug-path
GnRH signaling pathway	R-HSA-168638	map04912	cloperastine	23306	drug-path
Focal adhesion	R-HSA-354113	map04510	trioxysalen	657255	drug-path
B cell receptor signaling pathway	R-HSA-983705	map04662	trioxysalen	657255	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	trioxysalen	657255	drug-path
Olfactory transduction	R-HSA-9751605	map04740	trioxysalen	657255	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	trioxysalen	657255	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	trioxysalen	657255	drug-path
Parkinson's disease	R-HSA-1643685	0	trioxysalen	657255	drug-path
Cytokine-cytokine receptor interaction	R-HSA-6788467	map04060	trioxysalen	657255	drug-path
Amyotrophic lateral sclerosis (ALS)	Q8NDH6-2	0	flecainide	3356	drug-path